Here's the live share price of Vista Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Vista Pharmaceuticals has gained 1.40% CAGR. Over the past year, the corresponding return has been -28.89%.
Vista Pharmaceuticals’s current P/E of -11.69x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Vista Pharmaceuticals | -3.88 | -8.18 | -13.22 | -12.27 | -28.89 | 2.93 | 1.4 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.7 |
Torrent Pharmaceuticals | -1.1 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.5 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.6 | 3.02 | 4.4 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.9 | -2.43 | 2.84 | 7.47 | 21.3 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.4 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.2 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.6 | -2.3 | 24.69 | 9.19 |
Cohance Lifesciences | -2.3 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.3 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.1 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Vista Pharmaceuticals has declined 28.89% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Vista Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 9.95 | 9.91 |
10 | 9.95 | 9.96 |
20 | 10.1 | 10.1 |
50 | 10.57 | 10.39 |
100 | 10.72 | 10.64 |
200 | 10.86 | 11.07 |
In the latest quarter, Vista Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.02%, FII holding unchanged at 0.00%, and public shareholding unchanged at 78.78% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 08, 2025, 9:49 PM IST | Vista Pharmaceut - Intimation Of Book Closure Regarding 34" Annual General Meeting |
Sep 08, 2025, 9:46 PM IST | Vista Pharmaceut - Reg. 34 (1) Annual Report. |
Sep 08, 2025, 9:32 PM IST | Vista Pharmaceut - 34Th Annual General Meeting Of Vista Pharmaceuticals Limited On Tuesday, 30Th September 2025 |
Aug 14, 2025, 12:01 AM IST | Vista Pharmaceut - Re-Appointment Of Mr. Murali Meraga (DIN: 02537507) As An Managing Director Of The Company |
Aug 13, 2025, 11:58 PM IST | Vista Pharmaceut - Re-Appointment Of Mr. Pavan Sathvik Gilaka (DIN: 09733182) As An Whole Time Director Of The Company |
Vista Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 25/01/1991 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1991PLC012264 and registration number is 012264. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 10.07 Cr. and Equity Capital is Rs. 12.31 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vista Pharmaceuticals is ₹9.65 as on Sep 17, 2025.
The Vista Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vista Pharmaceuticals is ₹59.40 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Vista Pharmaceuticals are ₹10.43 and ₹9.63.
The 52-week high/low is the highest and lowest price at which Vista Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Vista Pharmaceuticals is ₹14.85 and 52-week low of Vista Pharmaceuticals is ₹9.10 as on Sep 17, 2025.
The Vista Pharmaceuticals has shown returns of -3.02% over the past day, -8.18% for the past month, -13.22% over 3 months, -28.89% over 1 year, 2.93% across 3 years, and 1.4% over 5 years.
P/E ratio of and PB ratio of Vista Pharmaceuticals are -11.69 and 1.37 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.